NeoGenomics Inc (NEO)
15.39
+0.03
(+0.20%)
USD |
NASDAQ |
Nov 21, 16:00
15.38
0.00 (0.00%)
After-Hours: 20:00
NeoGenomics Debt to Equity Ratio: 0.595 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.595 |
| June 30, 2024 | 0.5892 |
| March 31, 2024 | 0.5836 |
| December 31, 2023 | 0.5716 |
| September 30, 2023 | 0.5673 |
| June 30, 2023 | 0.5613 |
| March 31, 2023 | 0.5501 |
| December 31, 2022 | 0.5364 |
| September 30, 2022 | 0.5278 |
| June 30, 2022 | 0.5116 |
| March 31, 2022 | 0.496 |
| December 31, 2021 | 0.4805 |
| September 30, 2021 | 0.4677 |
| June 30, 2021 | 0.4629 |
| March 31, 2021 | 0.6286 |
| December 31, 2020 | 0.2421 |
| September 30, 2020 | 0.2498 |
| June 30, 2020 | 0.2515 |
| March 31, 2020 | 0.1893 |
| December 31, 2019 | 0.1908 |
| September 30, 2019 | 0.1997 |
| June 30, 2019 | 0.2027 |
| March 31, 2019 | 0.3053 |
| December 31, 2018 | 0.3144 |
| September 30, 2018 | 0.3195 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.7751 |
| March 31, 2018 | 0.4256 |
| December 31, 2017 | 0.4641 |
| September 30, 2017 | 0.4798 |
| June 30, 2017 | 0.5046 |
| March 31, 2017 | 0.5157 |
| December 31, 2016 | 0.5139 |
| September 30, 2016 | 0.2147 |
| June 30, 2016 | 0.2173 |
| March 31, 2016 | 0.2203 |
| December 31, 2015 | 0.2596 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.0022 |
| September 30, 2014 | 0.0883 |
| June 30, 2014 | 0.086 |
| March 31, 2014 | 0.2162 |
| December 31, 2013 | 0.1972 |
| September 30, 2013 | 0.1346 |
| June 30, 2013 | 0.1642 |
| March 31, 2013 | 0.2225 |
| December 31, 2012 | 0.9178 |
| September 30, 2012 | 0.8713 |
| June 30, 2012 | 0.6578 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1893
Minimum
Mar 2020
0.6286
Maximum
Mar 2021
0.4627
Average
0.5197
Median
Debt to Equity Ratio Benchmarks
| Bruker Corp | 1.271 |
| Henry Schein Inc | 0.7574 |
| Karyopharm Therapeutics Inc | -1.194 |
| Apellis Pharmaceuticals Inc | 1.907 |
| Beam Therapeutics Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.641B |
| Total Liabilities (Quarterly) | 732.90M |
| Shareholders Equity (Quarterly) | 908.21M |
| Current Ratio | 1.991 |
| Net Debt Paydown Yield | -0.04% |